ERBB2 and colorectal carcinoma: Park et al (10) revealed HER-2 overexpression in 47.4% of 137 patients with CRC, whereas Antonacopoulou et al (16) observed overexpression in 24.7% of 124 patients using IHC performed on whole sections.